Justin Hall, Interim President & CEO and GC at NovaBay Pharmaceuticals, Inc. (NBY), sold 47,500 shares at $3.03 ($144K) on 2019-06-10, disclosed to the SEC on 2019-10-28.
Open-market sale of $144k NBY by Interim President & CEO and GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |